Celgene Corp (NASDAQ:CELG)

87.72
Delayed Data
As of Sep 21
 -0.58 / -0.66%
Today’s Change
74.13
Today|||52-Week Range
147.17
-15.94%
Year-to-Date
3 Top Biotech Stocks to Buy Right Now
Sep 23 / MotleyFool.com - Paid Partner Content
Why bluebird and Celgene Should Worry About Amgen's Latest Clinical Victory
Sep 14 / MotleyFool.com - Paid Partner Content
Top 5 ROE Picks as Markets Shrug Off Heightened Trade Fears
Sep 21 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Illumina, Celgene , Athersys and Achillion
Sep 14 / Zacks.com - Paid Partner Content
Celgene (CELG) Outpaces Stock Market Gains: What You Should Know
Sep 20 / Zacks.com - Paid Partner Content
IPOs and Foreign Investment Propel Biotech: 4 Top Picks
Sep 13 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Regeneron Pharmaceuticals, Celgene, Sanofi and Gil...
Sep 20 / Zacks.com - Paid Partner Content
Zacks.com featured highlights include: Nucor, PCM, Celgene and Rayonier
Sep 13 / Zacks.com - Paid Partner Content
Bristol-Myers' MM Drug Empliciti Application Validated by EMA
Sep 19 / Zacks.com - Paid Partner Content
Celgene (CELG) Stock Sinks As Market Gains: What You Should Know
Sep 12 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: CELG, REGN Present Data, VKTX Soars on Drug's Success
Sep 19 / Zacks.com - Paid Partner Content
Boost Your Portfolio With These 4 High Earnings Yield Stocks
Sep 12 / Zacks.com - Paid Partner Content
3 High-Quality Biotech Companies for 4th Quarter
Sep 17 / GuruFocus News - Paid Partner Content
Endocyte Announces FDA's Acceptance of Trial Endpoint Change
Sep 11 / Zacks.com - Paid Partner Content
Better Buy: Celgene Corp. vs. Biogen
Sep 17 / MotleyFool.com - Paid Partner Content